Adam Jeffery News pharmaphorum welcomes George Underwood to its editorial helm With its focus always on top quality, engaging editorial content, pharmaphorum is pleased to announce that George Underwood has taken up the position of Features Editor, effective Dec 3rd Press releases Partner Content Predictions for 2019: Ten trends that will shape the future ... eBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead Digital The future of pharma in a digital world How is digital health impacting pharma? An exclusive live broadcast from Frontiers Health 2018 addressed this subject on 15 November. Partner Content Partner Content Leadership: Cultivating a Culture of High Curiosity The bar is set high for Medical Affairs (MA) talent: traditional capabilities are no longer sufficient to address Load more results
News pharmaphorum welcomes George Underwood to its editorial helm With its focus always on top quality, engaging editorial content, pharmaphorum is pleased to announce that George Underwood has taken up the position of Features Editor, effective Dec 3rd
Press releases Partner Content Predictions for 2019: Ten trends that will shape the future ... eBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead
Digital The future of pharma in a digital world How is digital health impacting pharma? An exclusive live broadcast from Frontiers Health 2018 addressed this subject on 15 November.
Partner Content Partner Content Leadership: Cultivating a Culture of High Curiosity The bar is set high for Medical Affairs (MA) talent: traditional capabilities are no longer sufficient to address
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
